Open Drug Discovery Teams: A Chemistry Mobile App for Collaboration

The Open Drug Discovery Teams (ODDT) project provides a mobile app primarily intended as a research topic aggregator of predominantly open science data collected from various sources on the internet. It exists to facilitate interdisciplinary teamwork and to relieve the user from data overload, delivering access to information that is highly relevant and focused on their topic areas of interest. Research topics include areas of chemistry and adjacent molecule‐oriented biomedical sciences, with an emphasis on those which are most amenable to open research at present. These include rare and neglected diseases, and precompetitive and public‐good initiatives such as green chemistry. The ODDT project uses a free mobile app as user entry point. The app has a magazine‐like interface, and server‐side infrastructure for hosting chemistry‐related data as well as value added services. The project is open to participation from anyone and provides the ability for users to make annotations and assertions, thereby contributing to the collective value of the data to the engaged community. Much of the content is derived from public sources, but the platform is also amenable to commercial data input. The technology could also be readily used in‐house by organizations as a research aggregator that could integrate internal and external science and discussion. The infrastructure for the app is currently based upon the Twitter API as a useful proof of concept for a real time source of publicly generated content. This could be extended further by accessing other APIs providing news and data feeds of relevance to a particular area of interest. As the project evolves, social networking features will be developed for organizing participants into teams, with various forms of communication and content management possible.

[1]  David A. Fidock,et al.  Drug discovery: Priming the antimalarial pipeline , 2010, Nature.

[2]  D. Pompliano,et al.  Nat. Rev. Drug Disc. , 2007 .

[3]  F. Collins Reengineering Translational Science: The Time Is Right , 2011, Science Translational Medicine.

[4]  Robert A. Field,et al.  New Small-Molecule Synthetic Antimycobacterials , 2005, Antimicrobial Agents and Chemotherapy.

[5]  Steve Pettifer,et al.  Utopia documents: linking scholarly literature with research data , 2010, Bioinform..

[6]  P. Escalante Tuberculosis , 1904, Annals of Internal Medicine.

[7]  Pedro M Alzari,et al.  Rising standards for tuberculosis drug development. , 2008, Trends in pharmacological sciences.

[8]  Barend Mons,et al.  Collaboration and the Semantic Web , 2011 .

[9]  P. Anastas,et al.  Green Chemistry , 2018, Environmental Science.

[10]  Daniel Cressey,et al.  Traditional drug-discovery model ripe for reform , 2011, Nature.

[11]  Sean Ekins,et al.  A collaborative database and computational models for tuberculosis drug discovery. , 2010, Molecular bioSystems.

[12]  R. Rosenfeld Nature , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[13]  Anthony J Williams,et al.  Public chemical compound databases. , 2008, Current opinion in drug discovery & development.

[14]  Antony J. Williams,et al.  ChemSpider:: An Online Chemical Information Resource , 2010 .

[15]  Sean Ekins,et al.  Redefining Cheminformatics with Intuitive Collaborative Mobile Apps , 2012, Molecular informatics.

[16]  Susie Stephens,et al.  Is open innovation the way forward for big pharma? , 2010, Nature Reviews Drug Discovery.

[17]  Peter A Merkel,et al.  Clinical research for rare disease: opportunities, challenges, and solutions. , 2009, Molecular genetics and metabolism.

[18]  Sean Ekins,et al.  Meta-analysis of molecular property patterns and filtering of public datasets of antimalarial “hits” and drugs , 2010 .

[19]  Nitin Kumar,et al.  TBrowse: an integrative genomics map of Mycobacterium tuberculosis. , 2009, Tuberculosis.

[20]  Alex M. Clark,et al.  Basic primitives for molecular diagram sketching , 2010, J. Cheminformatics.

[21]  Pam van Schaik,et al.  Today , 2013 .

[22]  Frederic Bost,et al.  Informatics for neglected diseases collaborations. , 2010, Current opinion in drug discovery & development.

[23]  김삼묘,et al.  “Bioinformatics” 특집을 내면서 , 2000 .

[24]  Antony J. Williams,et al.  Current and Future Challenges for Collaborative Computational Technologies for the Life Sciences , 2011 .

[25]  Antony J. Williams,et al.  The Spectral Game: leveraging Open Data and crowdsourcing for education , 2009, J. Cheminformatics.

[26]  Sean Ekins,et al.  Mobile apps for chemistry in the world of drug discovery. , 2011, Drug discovery today.

[27]  Antony J. Williams,et al.  Collaborative Computational Technologies for Biomedical Research: Ekins/Collaborative Computational , 2011 .

[28]  Ying Zhang,et al.  The magic bullets and tuberculosis drug targets. , 2005, Annual review of pharmacology and toxicology.

[29]  Sean Ekins,et al.  Novel web-based tools combining chemistry informatics, biology and social networks for drug discovery. , 2009, Drug discovery today.

[30]  G. Brewer Drug development for orphan diseases in the context of personalized medicine. , 2009, Translational research : the journal of laboratory and clinical medicine.

[31]  Sean Ekins,et al.  Analysis and hit filtering of a very large library of compounds screened against Mycobacterium tuberculosis. , 2010, Molecular bioSystems.

[32]  Anang A. Shelat,et al.  Chemical genetics of Plasmodium falciparum , 2010, Nature.

[33]  E. Kakkis,et al.  The potential investment impact of improved access to accelerated approval on the development of treatments for low prevalence rare diseases , 2011, Orphanet journal of rare diseases.

[34]  A. Hunter,et al.  The Innovative Medicines Initiative: a pre-competitive initiative to enhance the biomedical science base of Europe to expedite the development of new medicines for patients. , 2008, Drug discovery today.

[35]  James R. Brown,et al.  Thousands of chemical starting points for antimalarial lead identification , 2010, Nature.